GlassScriptPhysician profile
Steven J Weiss
NPI 1427294594
$3,849.82
in general payments reported to CMS, 2019-2025
11 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,355 · 2020: $1,594 · 2021: $218 · 2022: $21.17 · 2023: $108 · 2024: $109 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,566.11 | 2020-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Livanova USA, INC. | $1,300.40 | 2019-2020 | |
| Medtronic, INC. | $558.76 | 2021-2025 | Corevalve Evolut R |
| Atricure, INC. | $125.25 | 2024-2025 | Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $119.66 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $78.55 | 2019-2021 | |
| Ge Healthcare | $28.99 | 2020 | |
| Pfizer INC. | $22.53 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $21.17 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.50 | 2025 | Qelbree |
| Getinge USA Sales, LLC | $12.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.